DNA topoisomerase I and IIα expression in penile carcinomas: Assessing potential tumour chemosensitivity

BJU International

Volumn 102, Issue 8, 2008, Pages 1040-1044

  Berney, Daniel M ^a,b   Stankiewicz, Elzbieta ^b   Adlan, Ahmed M A ^b   Kudahetti, Sakunthala ^c   Biedrzycki, Olaf J ^b   Hadway, Paul ^c   Watkin, Nick ^c   Corbishley, Cathy ^c  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Chemotherapy; Penis; Topoisomerase

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IIALPHA; KI 67 ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; PENILE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 52649144319     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07698.x     Document Type: Article

References (21)

1. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL. The penis. In Rosai J, Sobin LH eds, Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis, 3rd edn. Chapt 10. Washington : Armed Forces Institute of Pathology, 1998 : 403 95
2. Rubin MA, Kleter B, Zhou M et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001 159 : 1211 8
3. Sarkar FH, Miles BJ, Plieth DH, Crissman JD. Detection of human papillomavirus in squamous neoplasm of the penis. J Urol 1992 147 : 389 92
4. Cubilla AL, Velazquez EF, Young RH. Epithelial lesions associated with invasive penile squamous cell carcinoma: a pathologic study of 288 cases. Int J Surg Pathol 2004 12 : 351 64
5. Akduman B, Fleshner NE, Ehrlich L, Klotz L. Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe. Urology 2001 58 : 65 8
6. Joerger M, Warzinek T, Klaeser B, Kluckert JT, Schmid HP, Gillessen S. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004 63 : 778 80
7. Preis E, Albers P, Jakse G. [Systemic therapy of penile cancer]. Urologe A 2006 45 : 609 13
8. Skeel RT, Huang J, Manola J et al. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Cancer Invest 2003 21 : 41 6
9. Nitiss JL. DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage. Curr Opin Invest Drugs 2002 3 : 1512 6
10. Holden JA. DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic. Curr Med Chem Anticancer Agents 2001 1 : 1 25
11. Zhang W, Shannon WD, Duncan J, Scheffer GL, Scheper RJ, McLeod HL. Expression of drug pathway proteins is independent of tumour type. J Pathol 2006 209 : 213 9
12. Hafian H, Venteo L, Sukhanova A, Nabiev I, Lefevre B, Pluot M. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas. Hum Pathol 2004 35 : 745 51
13. Robert F, Soong SJ, Wheeler RH. A phase II study of topotecan in patients with recurrent head and neck cancer. Identification of an active new agent. Am J Clin Oncol 1997 20 : 298 302
14. Davidson B, Goldberg I, Lerner-Geva L et al. Expression of topoisomerase II and Ki-67 in cervical carcinoma - clinicopathological study using immunohistochemistry. APMIS 2000 108 : 209 15
15. Horibe Y, Murakami M, Komori K, Imaeda Y, Kasahara M. Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation. APMIS 2000 108 : 689 96
16. Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Anticancer Res 2000 20 : 177 82
17. Berdjis N, Meye A, Nippgen J et al. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int 2005 96 : 146 8
18. Medina PM, Valero PJ, Martinez Igarzabal MJ. [Verrucous carcinoma of the penis with intense basal expression of Ki 67]. Arch Esp Urol 1999 52 : 983 5
19. Brustmann H, Naude S. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 2002 86 : 192 9
20. Long HJ III, Bundy BN, Grendys EC et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005 23 : 4626 33
21. Monk BJ, Huang HQ, Cella D, Long HJ III. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005 23 : 4617 25